Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100

Clinical trial NCT01935869 · COMPLETED

Trial details

NCT number: NCT01935869
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 2013-08-01
Primary completion: 2013-11-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.